Biofrontera AG American Depositary Shares
BFRA
BFRA was delisted on the 4th of March, 2022.
2 hedge funds and large institutions have $95K invested in Biofrontera AG American Depositary Shares in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
4,650% more capital invested
Capital invested by funds: $2K → $95K (+$93K)
100% more funds holding
Funds holding: 1 → 2 (+1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Squarepoint
New York
|
+$113K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$984 |
BFRA Hedge Fund Activity: Q3 2020 in Review
2 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Biofrontera AG American Depositary Shares (BFRA) for Q3 2020, worth a combined $95K — up 4,650% from $2K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BFRA positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Squarepoint, opening a new position worth an estimated $113K. The largest seller was UBS Group, cutting an estimated $984.
- 2 institutional investors held Biofrontera AG American Depositary Shares (BFRA) as of Q3 2020, up from 1 in Q2 2020.
- Funds reported $95K of Biofrontera AG American Depositary Shares stock for Q3 2020, up 4,650% quarter-over-quarter.
- 1 fund opened new Biofrontera AG American Depositary Shares positions in Q3 2020 and 0 closed out, a net change of +1 holder.
- The largest Biofrontera AG American Depositary Shares buyer in Q3 2020 was Squarepoint, an estimated $113K added.
- The largest Biofrontera AG American Depositary Shares seller in Q3 2020 was UBS Group, an estimated $984 sold.
Based on aggregated 13F filings for Q3 2020.